MedWorm: Expenditures News
Regeneron Pharmaceuticals could increase its capital expenditures by more than $100 million this year. The manufacturer of bulk medications for treating skin cancer, eye disease and asthma plans to invest up to $490 million on renovations and expansion of its factories in East Greenbush, New York, and Limerick, Ireland.